CAR T-cell therapy bb2121 performs well in phase 1 trial of refractory multiple myelomaMay 1, 2019Multiple Myeloma
Quality of life decrement with salvage ASCT is short-livedApril 23, 2019Multiple MyelomaTransplantPatient & Survivor Care
MRD negativity linked to survival in MM after auto-HCTFebruary 24, 2019Multiple MyelomaCellular Therapy
